bg-img9.jpg
8.jpg
Fisher BioServices Top Five Most Popular Blogs of 2016

2016 has been a year filled with new discoveries in the health and medical R&D space. Through our blog, we have shared great stories of our customers' work and discussed a wide-breadth of topics, focusing on cell therapies, biological material, and public health research.

Content: Blog

The Evolution of Public Health Research: Malaria, Part 1

Mosquitoes, the Military, and Why the CDC is in Atlanta

To most of us in the US, malaria is a health problem restricted to distant parts of the globe. Even in the international media, the disease receives little attention. However, it has only been since 1949 that Malaria was declared “eliminated” in the US.

Topic: Public Health Research, The Evolution of Pu..........

Amazing Samples: A Compilation of Stories in Our Cells

Though small, biological samples hold a wealth of information. They are the foundation for the development of new therapies as well as research into the cause of disease.  

Content: eBook, Topic: Amazing Samples

Radiation Therapy for Cancer Treatment is Undergoing a Personalized Medicine Transformation

Personalized medicine, sometimes called precision medicine, has become a major buzzword in the pharmaceutical industry. For decades, scientists and physicians have puzzled over why some treatments are very successful for one patient, while other seemingly similar patients given the same treatment fail to get better. The idea behind personalized medicine is that by characterizing genetic factors, epigenetic information, levels of RNA expression, and other individual factors, we can better target our treatments to the people most likely to respond to them.

Topic: Cell Therapy Solutions

Cell Therapy Manufacturing & Gene Therapy Congress

We are pleased to announce our participation as a sponsor at the upcoming Cell Therapy Manufacturing & Gene Therapy Congress in Amsterdam. The event will focus on connecting cell and gene therapy leads to drive manufacturing and commercialization through direct access to innovative discovery, product development and regulatory know-how. We are honored to showcase our global integrated solution for cell therapy clinical and commercial development in conjunction with our parent company, Thermo Fisher Scientific.

Topic: Cell Therapy Solutions, Content: Blog

Supporting our Troops - Transporting the AFMES DNA Repository to Dover Air Force Base

In observance of the upcoming Veterans Day holiday on November 11, we'd like to share a case study on how the Fisher BioServices team actively supports our troops and share our appreciation for all that they do. Together with our parent company, Thermo Fisher Scientific, we work with veterans to make the world a healthier place.

Topic: Biobanking and Biorepository, Topic: Cold-C..........

Creation of the First Tuberculosis Biobank in the UK

After the discovery of Streptomycin in the 1940s, followed by isoniazid in the 1950s and later rifampin in the 1970s, the incidence of Tuberculosis (TB) in the developed world dropped dramatically. Sanatoria closed and research into new antibiotics and vaccines likewise diminished. TB was no longer considered a significant threat in the US and much of Europe. So when multiple drug-resistant strains of TB (MDR-TB) appeared in the 1980s, the concern within the infectious disease community was perhaps understated. Besides, all but a small number of cases were in underdeveloped countries where the very high cost and difficulty of treating MDR-TB was considered beyond reach.

Topic: Biobanking and Biorepository, Content: Post..........

ISBER Regional Meeting: Quality Biobanking for Precision Research and Medicine

We are pleased to announce our participation at the International Society for Biological and Environmental Repositories (ISBER) 2016 Regional Meeting in Bethesda, Maryland on November 7-8. This year's theme, Quality Biobanking for Precision Research and Medicine, will focus on overcoming scientific, information technology and policy challenges. This regional event allows for greater opportunity for interactions between attendees and a focus on regional issues.

Topic: Biobanking and Biorepository, Topic: Public..........

Decentralized Manufacture: The Drivers and Barriers

The emergence of advanced therapeutics, including cell and gene-based therapies (CGTs), presents significant opportunities for treating unmet clinical needs, and specifically, has demonstrated the potential to provide personalized therapies. Amidst the exciting science and clinical opportunities however, there are unique challenges that arise from manufacturing and delivering patient-specific CGTs.

Topic: Cell Therapy Solutions, Content: Blog

An Alternative Model for Clinical Trial Product Management: Exploring Distribution and Dispensing

Managing limited supplies of an investigational agent in a clinical trial can present challenges. The typical practice is to ship inventory to the research pharmacy or the principal investigator’s office at clinical a site in anticipation of enrollment. One challenge is that the amount needed at study sites can only be estimated, and inadequate inventory may delay the study while providing extra is expensive and wasteful. In the meantime, the agent(s) and clinical supplies sit in storage until enrollment proceeds and dispensing begins. This ties up inventory and can create additional challenges with expiration dates. However, there is an alternative model of clinical trial support for consideration.

Topic: Clinical Trial Sample Management, Content: ..........

The Evolution of Public Health Research: Heart Disease, Part 2

Smoking, Salt and the Downside of Success

In the past 55 years, death rates from cardiovascular disease have declined by 68 percent—a two thirds reduction in mortality. Over the same period of time, death from stroke has declined by more than three fourths.

Topic: Public Health Research, The Evolution of Pu..........

Chemical Storage in the Contract Environment

When we think of chemical storage we tend to think of large warehouses or factories designed to store chemicals in large quantities. However, the standards and regulatory requirements required of large chemical facilities still have to be met by smaller facilities. In smaller facilities and laboratories, chemical storage is often secondary to other tasks and functions. There are still a number of things you must do even if your primary business is not managing chemicals. In this blog, we’ll explore some of the necessary steps to properly manage chemicals as well as protect employee well-being. 

Topic: Biobanking and Biorepository, Topic: GMP Bi..........